Prothena Corporation plc Live Stock Price Today, Share Analysis and Chart

Name: Prothena Corporation plc: Is Infosys Ltd. worth buying?
Item: Prothena Corporation plc
Rating: 1.86966675
Author: Trendlyne DVM scores

about

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseas...

10.00 -0.34 (-3.29%)

39.98% Fall from 52W High

659.4K

XNAS Volume

XNAS 23 Jan, 2026 4:17 PM (EST)

Not Eligible

Expensive Valuation

14.7 / 100

Technically Moderately Bullish

60.1 / 100

1Yr Price target upside is 103%

6 analysts

Prothena Corporation plc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Prothena Corporation plc Live Stock Price Today, Share Analysis and Chart

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseas...

39.98% Fall from 52W High

SWOT Analysis

Prothena Corporation plc Live Price Chart